mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.01 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.02 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |